Sort
64,565 grants matching “drug discovery”
Broad-spectrum Antifolates for Treatment of Drug Resistant Bacillus anthracis
$491,851Richard A Bunce · Oklahoma State University Stillwater · R01 · FY2014 · AI
Investigating the CDC42 pathway as a novel pathway for pediatric non-atopic obesity-related asthma
$491,841Deepa Rastogi · Children'S Research Institute · R01 · FY2020 · HL
A Multidisciplinary Analysis of Gelsolin Amyloid Disease
$491,825Scripps Research Institute · R01 · FY2002 · AG
AutoDock Software Development and Maintenance
$491,804Arthur J. Olson · Scripps Research Institute, The · R01 · FY2013 · GM
Discovery of bacterial defense and phage counter-defense strategies
$491,750Kevin J Forsberg · Ut Southwestern Medical Center · DP2 · FY2021 · AI
Targeting DNA repair in KRAS mutated lung cancer by chemical screening
$491,730You-Wei Zhang · Case Western Reserve University · R01 · FY2020 · CA
Defining the Pathogenesis and Prognosis of Human Acute Interstitial Nephritis
$491,708Lloyd G Cantley · Yale University · R01 · FY2023 · DK
Chemical Probes for Metabolic Pathway Discovery in Human Disease
$491,691Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2014 · CA
METHOD FOR MAKING AN IMPROVED ST JOHN'S WORT PRODUCT
$491,665Aphios Corporation · R44 · FY2000 · AT
Product Development Core
$491,612Julian P Whitelegge · University Of California Los Angeles · U19 · FY2016 · AI
DRUG DISCOVERY CORE FACILITY (DDCF)
$491,588Kinfe Ken Redda · Florida Agricultural And Mechanical Univ · G12 · FY2011 · RR
Regulation of apoptosis by PI 3-kinase/Akt signaling
$491,571Geoffrey M Cooper · Boston University (Charles River Campus) · R01 · FY2010 · CA
The Role of PI3K in Growth Regulation
$491,550Lewis C Cantley · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · GM
The Role of PI3K in Growth Regulation
$491,550Lewis C Cantley · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · GM
The Role of PI3K in Growth Regulation
$491,550Lewis C Cantley · Weill Medical Coll Of Cornell Univ · R01 · FY2014 · GM
SYSTEM FOR AUTOMATED NONINVASIVE MONITORING OF MOUSE SLEEP AND BEHAVIOR
$491,450Michael E Lhamon · Signal Solutions, Llc · R44 · FY2016 · NS
Medicinal chemistry campaign to synthesize synaptamide analogs (GPR110)
$491,448Juan Marugan · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Identification of small molecule that selectively modulate Ghrelin receptor (GHSR1a) b-arrestin signaling as a new therapeutic approach for the treatment of addiction
$491,448Juan Marugan · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
PAC1 receptor antagonists as potential treatments for depression and atherosclerosis associated with chronic stress
$491,448Juan Marugan · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Identification of novel agonist of the Relaxin family peptide receptor 2 (RXFP2) as potential new therapeutics for testicular maldescent
$491,448Juan Marugan · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
CD206 activators as novel immunomodulators
$491,448Juan Marugan · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Small molecule agonists of the relaxin 1 receptor
$491,448Juan Marugan · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Multi-Center Validation of Biomarkers for Motor Neuron Disease
$491,399Robert P Bowser · University Of Pittsburgh At Pittsburgh · RC1 · FY2009 · NS
Bridging Pediatric and Adult Biomarkers of Graft-Versus-Host-Disease
$491,398Sophie Paczesny · Indiana University Indianapolis · R01 · FY2017 · HD
Identifying ancestry-specific and distal components of disease-associated gene regulation and cellular function
$491,366Tiffany Amariuta-Bartell · University Of California, San Diego · R01 · FY2025 · HG